EWTX
Edgewise Therapeutics, Inc.
Set alert
38.90 USD -0.01 -0.03%
38.02 Day range 39.44
17.09 52-week range 48.35
- YTD
- +56.73%
- 1 year
- +108.36%
- Open
- 38.72
- Prev close
- 38.91
- Mkt cap
- 4.22B
- Vol
- 967.63K
- Avg vol
- 1.46M
- EPS
- -1.86
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 38.02
- High
- 39.44
- Forward P/E
- -21.93
- Beta
- 0.35
- Short ratio
- 6.61
- Inst. own
- 112.25%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 41.43
- 200-d avg
- 36.22
- 1y target
- 52.62
Financial health
Altman Z-Score
77.29 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -15.2×
FY 2019 5y median -15.2× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 4.9×
FY 2019 5y median 2.8× FY 2025
P/FCF -17.8×
FY 2019 5y median -17.8× FY 2025
EV/EBITDA -15.1×
FY 2019 5y median -15.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -5.6%
FY 2019 5y median -5.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -32.1%
FY 2019 5y median -29.1% FY 2025
ROIC -36.4%
FY 2019 5y median -34.2% FY 2025
ROA -30.4%
FY 2019 5y median -27.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -20.5%
FY 2019 FY 2025
EPS (diluted) -12.4%
FY 2019 FY 2025
Free Cash Flow -30.3%
FY 2019 FY 2025
Financial Health
Current Ratio 19.9×
FY 2019 5y median 19.9× FY 2025
Quick Ratio 19.9×
FY 2019 5y median 19.9× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31